BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15683429)

  • 21. High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1.
    Kuramochi H; Hayashi K; Uchida K; Nakajima G; Hatori T; Danenberg KD; Danenberg PV; Yamamoto M
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):85-9. PubMed ID: 18309485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
    Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
    Tan X; Egami H; Nozawa F; Abe M; Baba H
    Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and significance of urokinase type plasminogen activator gene in human brain gliomas.
    Zhang X; Fei Z; Bu X; Zhen H; Zhang Z; Gu J; Chen Y
    J Surg Oncol; 2000 Jun; 74(2):90-4. PubMed ID: 10914816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of E-cadherin and uPA and their association with the prognosis of pancreatic cancer.
    Shin SJ; Kim KO; Kim MK; Lee KH; Hyun MS; Kim KJ; Choi JH; Song HS
    Jpn J Clin Oncol; 2005 Jun; 35(6):342-8. PubMed ID: 15937032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
    J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
    Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
    Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation.
    Brevet M; Fucks D; Chatelain D; Regimbeau JM; Delcenserie R; Sevestre H; Ouadid-Ahidouch H
    Pancreas; 2009 Aug; 38(6):649-54. PubMed ID: 19465885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of synuclein-gamma in pancreatic adenocarcinoma.
    Li Z; Sclabas GM; Peng B; Hess KR; Abbruzzese JL; Evans DB; Chiao PJ
    Cancer; 2004 Jul; 101(1):58-65. PubMed ID: 15221989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor.
    Ito T; Ito M; Shiozawa J; Naito S; Kanematsu T; Sekine I
    Mod Pathol; 1999 Jul; 12(7):669-74. PubMed ID: 10430270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and significance of urokinase-type plasminogen activator in human gliomas.
    Zhang X; Bu X; Zhen H; Fei Z; Wu J; Gu J; Yi S; Wang Z
    Chin Med J (Engl); 2000 Sep; 113(9):802-4. PubMed ID: 11776074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer.
    Steiner E; Pollow K; Hasenclever D; Schormann W; Hermes M; Schmidt M; Puhl A; Brulport M; Bauer A; Petry IB; Koelbl H; Hengstler JG
    Gynecol Oncol; 2008 Mar; 108(3):569-76. PubMed ID: 18222533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.
    Trauzold A; Röder C; Sipos B; Karsten K; Arlt A; Jiang P; Martin-Subero JI; Siegmund D; Müerköster S; Pagerols-Raluy L; Siebert R; Wajant H; Kalthoff H
    FASEB J; 2005 Apr; 19(6):620-2. PubMed ID: 15670977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
    Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the expression of the gene encoding Ki-67 antigen in human pancreatic cancer using non-radioactive in situ hybridization and immunohistochemistry.
    Wu Y; Peng S; Sheng H
    Chin Med J (Engl); 1997 Nov; 110(11):869-74. PubMed ID: 9772421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
    Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.